SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,457,596 | -48.0% | 2,773,811 | -7.9% | 0.00% | 0.0% |
| Q3 2022 | $4,726,000 | +21.2% | 3,010,140 | +55.2% | 0.00% | 0.0% |
| Q2 2022 | $3,900,000 | +6.1% | 1,939,979 | +23.0% | 0.00% | 0.0% |
| Q1 2022 | $3,675,000 | +24.9% | 1,577,066 | +149.2% | 0.00% | 0.0% |
| Q4 2021 | $2,942,000 | -35.5% | 632,781 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $4,561,000 | -18.5% | 597,766 | +3.5% | 0.00% | 0.0% |
| Q2 2021 | $5,598,000 | +3.0% | 577,743 | -12.1% | 0.00% | 0.0% |
| Q1 2021 | $5,437,000 | -72.6% | 657,373 | -77.4% | 0.00% | -80.0% |
| Q4 2020 | $19,857,000 | +52.0% | 2,909,373 | +148.3% | 0.01% | +25.0% |
| Q3 2020 | $13,062,000 | +167.8% | 1,171,552 | +50.8% | 0.00% | +300.0% |
| Q2 2020 | $4,878,000 | +159.6% | 776,761 | -23.9% | 0.00% | 0.0% |
| Q1 2020 | $1,879,000 | +165.4% | 1,020,866 | +387.4% | 0.00% | – |
| Q4 2019 | $708,000 | +326.5% | 209,457 | +170.1% | 0.00% | – |
| Q3 2019 | $166,000 | -20.6% | 77,559 | -0.9% | 0.00% | – |
| Q2 2019 | $209,000 | -60.8% | 78,264 | -30.2% | 0.00% | – |
| Q1 2019 | $533,000 | +77.1% | 112,154 | -10.8% | 0.00% | – |
| Q4 2018 | $301,000 | -73.3% | 125,720 | -50.9% | 0.00% | – |
| Q3 2018 | $1,127,000 | +63.1% | 256,150 | +166.8% | 0.00% | – |
| Q2 2018 | $691,000 | -71.6% | 96,003 | -79.7% | 0.00% | -100.0% |
| Q1 2018 | $2,432,000 | +1800.0% | 472,282 | +1297.2% | 0.00% | – |
| Q4 2017 | $128,000 | +412.0% | 33,803 | +128.9% | 0.00% | – |
| Q3 2017 | $25,000 | -95.6% | 14,767 | -94.8% | 0.00% | – |
| Q2 2017 | $565,000 | +370.8% | 282,690 | +832.6% | 0.00% | – |
| Q1 2017 | $120,000 | +20.0% | 30,312 | +48.8% | 0.00% | – |
| Q4 2016 | $100,000 | -19.4% | 20,367 | +26.8% | 0.00% | – |
| Q3 2016 | $124,000 | +103.3% | 16,057 | +47.0% | 0.00% | – |
| Q2 2016 | $61,000 | -6.2% | 10,920 | -8.2% | 0.00% | – |
| Q1 2016 | $65,000 | -44.0% | 11,901 | -10.1% | 0.00% | – |
| Q4 2015 | $116,000 | -96.3% | 13,244 | -96.4% | 0.00% | -100.0% |
| Q3 2015 | $3,108,000 | +785.5% | 370,396 | +1764.3% | 0.00% | – |
| Q2 2015 | $351,000 | -1.1% | 19,868 | -35.3% | 0.00% | – |
| Q1 2015 | $355,000 | +248.0% | 30,700 | +102.4% | 0.00% | – |
| Q2 2014 | $102,000 | – | 15,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |